The role of immune system in atherosclerosis: Molecular mechanisms, controversies, and future possibilities

Hum Immunol. 2024 Mar;85(2):110765. doi: 10.1016/j.humimm.2024.110765. Epub 2024 Feb 18.

Abstract

Numerous cardiovascular disorders have atherosclerosis as their pathological underpinning. Numerous studies have demonstrated that, with the aid of pattern recognition receptors, cytokines, and immunoglobulins, innate immunity, represented by monocytes/macrophages, and adaptive immunity, primarily T/B cells, play a critical role in controlling inflammation and abnormal lipid metabolism in atherosclerosis. Additionally, the finding of numerous complement components in atherosclerotic plaques suggests yet again how heavily the immune system controls atherosclerosis. Therefore, it is essential to have a thorough grasp of how the immune system contributes to atherosclerosis. The specific molecular mechanisms involved in the activation of immune cells and immune molecules in atherosclerosis, the controversy surrounding some immune cells in atherosclerosis, and the limitations of extrapolating from relevant animal models to humans were all carefully reviewed in this review from the three perspectives of innate immunity, adaptive immunity, and complement system. This could provide fresh possibilities for atherosclerosis research and treatment in the future.

Keywords: Adaptive immunity; Atherosclerosis; Complement system; Innate immunity; Pattern recognition receptors.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Atherosclerosis*
  • Humans
  • Immunity, Innate
  • Inflammation
  • Leukocytes / pathology